Literature DB >> 10759234

Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis.

H Kawai1, Y Aoyagi, M Nomoto, H Takizawa, Y Suzuki, A Hama, T Suda, T Takahashi, H Asakura.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10759234     DOI： 10.1023/a:1005427223036

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  23 in total

Review 1.  Primary sclerosing cholangitis: a clinical review.

Authors:  C I Ponsioen; G N Tytgat
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

2.  Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis.

Authors:  R Olsson; I Hägerstrand; U Broomé; A Danielsson; G Järnerot; L Lööf; H Prytz; B O Rydén; S Wallerstedt
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

3.  Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis.

Authors:  J Ludwig; S S Barham; N F LaRusso; L R Elveback; R H Wiesner; J T McCall
Journal:  Hepatology       Date:  1981 Nov-Dec       Impact factor: 17.425

4.  A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis.

Authors:  T A Knox; M M Kaplan
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

5.  Sclerosing cholangitis: broad spectrum of radiographic features.

Authors:  L Y Chen; H I Goldberg
Journal:  Gastrointest Radiol       Date:  1984

6.  Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients.

Authors:  J H Helzberg; J M Petersen; J L Boyer
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

7.  Primary sclerosing cholangitis: refinement and validation of survival models.

Authors:  E R Dickson; P A Murtaugh; R H Wiesner; P M Grambsch; T R Fleming; J Ludwig; N F LaRusso; M Malinchoc; R W Chapman; M M Kaplan
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

8.  The combination of prednisone and colchicine in patients with primary sclerosing cholangitis.

Authors:  K D Lindor; R H Wiesner; L J Colwell; B Steiner; S Beaver; N F LaRusso
Journal:  Am J Gastroenterol       Date:  1991-01       Impact factor: 10.864

9.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

10.  Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; W Irish; J McMichael; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.